ChristopherD.HillyerMD

Pathology • Atlanta, GA

Blood Banking & Transfusion Medicine, Transplantation Immunology, Clinical Pathology

Physician

Join to view full profile

Dr. Hillyer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hillyer's full profile

Already have an account?

Office
1364 Clifton Rd Ne
Euh Blood Bank, Room D655
Atlanta, GA 30322
Phone+1 404-712-5869

Fax+1 404-712-0893

Education & Training

Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1987 - 1990
Tufts Medical CenterResidency, Internal Medicine, 1984 - 1987
University of Rochester School of Medicine and DentistryClass of 1984

Certifications & Licensure

NJ State Medical License 2010 - 2025
NY State Medical License 2010 - 2025
CT State Medical License 2022 - 2023
GA State Medical License 1990 - 2013
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
American Board of Pathology Blood Banking/Transfusion Medicine

Clinical Trials

Retrovirus Epidemiology Donor Study-II (REDS-II) Start of enrollment: 2004 Sep 01
Completed
Optimal Platelet Dose Strategy for Management of Thrombocytopenia Start of enrollment: 2004 Jul 01
Completed
Phase 3
Fresh-Frozen Plasma Infusions to Reduce Risk of Bleeding Related to Invasive Procedures Start of enrollment: 2006 Mar 01
Withdrawn
Phase 3
Evaluating the Effectiveness of Adding Rituximab to Standard Treatment for Thrombotic Thrombocytopenic Purpura (TTP) Start of enrollment: 2009 Apr 01
Terminated
Phase 3
Join now to see all

Publications & Presentations

PubMed

864 citations
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.
Yiska Weisblum, Fabian Schmidt, Fengwen Zhang, Justin DaSilva, Daniel Poston
Elife. 2020-10-28
260 citations
Noninfectious serious hazards of transfusion.
Jeanne E. Hendrickson, Christopher D. Hillyer
Anesthesia and Analgesia. 2009-03-01
590 citations
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses.
Shibo Jiang, Christopher D. Hillyer, Lanying Du
Trends in Immunology. 2020-05-01

Journal Articles

Donor Incentives Improve Cardiovascular Disease Risk Profile and Donation Rates
Caroline Ortiz, Beth H Shaz, Christopher D Hillyer, Transfusion

Abstracts/Posters

Glucocorticoids Induce the Maintenance and Expansion of an Immature CFU-E Erythroid Progenitor Population in Humans
Christopher D. Hillyer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

Coronavirus Update: Blood Bank Renews Urgent Call for DonorsMay 15th, 2020
Blood Bank of Delmarva Issues Urgent Call for DonationsMay 14th, 2020
Testing an Old Therapy Against a New Disease: Convalescent Plasma for COVID-19May 1st, 2020
Join now to see all

Grant Support

Prevention Of Transfusion-Transmitted CMV In Low Birth Weight Infants Using Cmv..National Heart, Lung, And Blood Institute2011
Administrative CoreNational Heart, Lung, And Blood Institute2011
Retrovirus Epidemiology Donor Study-Ii (Reds-Ii) Blood CenterDivision Of Blood Diseases And Resources2009
Serious Hazards Of Transfusion &Cellular Therapies: Mechanisms And InterventionNational Heart, Lung, And Blood Institute2008
Development Of An ABO Incompatibility Stop Device (AISD)National Heart, Lung, And Blood Institute2008
Training Grant In Transfusion MedicineNational Heart, Lung, And Blood Institute2004–2008
Transfusion Medicine/Hemostasis Clinical Trails NetworkNational Heart, Lung, And Blood Institute2007
Transfusion Medicine/Hemostasis Clinical Research NetworNational Heart, Lung, And Blood Institute2002–2006
"Development Of A Laboratory Test For Ttp"National Heart, Lung, And Blood Institute2003
PCR Screening For CMV In Umbilical Cord Blood Stem CellsNational Heart, Lung, And Blood Institute2002–2003
Transfusion Transmission Of Cell-Associated InfectionsNational Heart, Lung, And Blood Institute2000–2003
SIV Infection Effect On Hematopoietic Stem CellsNational Center For Research Resources1999–2002
Effect Of Hematopoietic Cytokines On Model Of AIDSNational Center For Research Resources1999–2002
Hematopoetic Cytokines Effect On Model Of AIDSNational Center For Research Resources2000
Effect Of SIV Infection On Hematopoetic Stem CellsNational Center For Research Resources2000
SIV Infection Effect On Hematopoietic Stem CellsNational Heart, Lung, And Blood Institute1996–1999
Hematopoietic Cytokines Effect On A Model Of AIDSNational Heart, Lung, And Blood Institute1995–1998
Hematopoietic Cytokines Effect On Model Of AIDSNational Center For Research Resources1997
Effect Of Hematopoietic Cytokines On Rhesus Monkey Model Of AIDSNational Center For Research Resources1996